Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ENANTYUM 25 MG GRANULADO EN SOBRE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ENANTYUM 25 MG GRANULADO EN SOBRE

Approved

STANDARD

ENANTYUM 25 MG GRANULADO EN SOBRE

Laboratorios Menarini S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 31, 2021
Approval ID: 7ccc141c140b3801
Company: Laboratorios Menarini S.A.
Type: Standard

Approval Details

Approval Id: 7ccc141c140b3801
Drug Cima Aemps Name: ENANTYUM 25 MG GRANULADO EN SOBRE
Register Number: 85885
Holder Company Name: Laboratorios Menarini S.A.
Marketing Company Name: Laboratorios Menarini S.A.
Authorization Date: 2021-03-31
Dosage Form: GRANULADO EN SOBRE
Dose: 25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Laboratorios Menarini S.A.

Active Ingredients

DEXKETOPROFENO TROMETAMOL

36,91 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 31, 2021

Approval ID

7ccc141c140b3801

Type

Standard

Back to CIMA-AEMPS Approvals